Joel Lewis serves as Executive at GALECTIN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Joel Lewis has executed 115 insider transactions totaling $468.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 30, 2020 involved receiving (via award) 6,410 shares valued at $16.7K.
Joel Lewis currently holds 776,260 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel Lewis has been a net seller of GALT stock. They have purchased $79.5K and sold $388.5K worth of shares.
Joel Lewis's most recent insider trade was on Nov 30, 2020, when they sold 6,410 shares at $2.60 per share.
Get notified when new Form 4 filings are submitted
| $2.75 |
| Discretionary |
| Oct 30, 2020 | GALT | $16.7K | Award | 6,562 | $2.54 | Discretionary |
| Oct 15, 2020 | GALT | $16.7K | Award | 5,807 | $2.87 | Discretionary |
| Sep 30, 2020 | GALT | $16.7K | Award | 6,242 | $2.67 | Discretionary |
| Sep 15, 2020 | GALT | $15.2K | Award | 5,171 | $2.93 | Discretionary |
| Feb 9, 2020 | GALT | $19.1K | Option Exercise | 8,000 | $2.39 | Discretionary |
| Jan 9, 2020 | GALT | $58.5K | Award | 20,455 | $2.86 | Discretionary |
| May 31, 2019 | GALT | $55.0K | Purchase | 12,849 | $4.28 | Discretionary |
| Apr 5, 2019 | GALT | $3.2K | Purchase | 667 | $4.82 | Discretionary |
| Feb 7, 2019 | GALT | $4.5K | Purchase | 1,000 | $4.48 | Discretionary |
| Jan 29, 2019 | GALT | $4.8K | Purchase | 1,000 | $4.81 | Discretionary |
| Jan 16, 2019 | GALT | $55.0K | Award | 11,653 | $4.72 | Discretionary |
| Jun 25, 2018 | GALT | $7.1K | Purchase | 1,000 | $7.06 | Discretionary |
| Dec 14, 2017 | GALT | $55.0K | Award | 23,013 | $2.39 | Discretionary |